Aleutian Therapeutics is a pre-clinical stage company developing universal stem cells to enable scalable production of a variety of cell therapies. Our proprietary technology aims to restore cellular function in patients by administering engineered cells that evade the immune system. Our approach does not require cell encapsulation, surgical implantation, or toxic immunosuppressive drugs.  While our initial focus is on Type 1 diabetes, our technology has the potential to advance regenerative medicine in a wide variety of applications.